During the last session, Helius Medical Technologies Inc (NASDAQ:HSDT)’s traded shares were 67.45 million, with the beta value of the company hitting 1.13. At the end of the trading day, the stock’s price was $0.36, reflecting an intraday gain of 16.38% or $0.05. The 52-week high for the HSDT share is $24.00, that puts it down -6566.67 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.30. The company’s market capitalization is $0.19M, and the average intraday trading volume over the past 10 days was 34.48 million shares, and the average trade volume was 4.34 million shares over the past three months.
Helius Medical Technologies Inc (HSDT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HSDT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Helius Medical Technologies Inc (HSDT) registered a 16.38% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 16.38% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is -67.54%, and it has moved by -92.51% in 30 days. Based on these gigs, the overall price performance for the year is -97.62%. The short interest in Helius Medical Technologies Inc (NASDAQ:HSDT) is 62031.0 shares and it means that shorts have 1.98 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 63.29%. While earnings are projected to return 92.20% in 2025.
HSDT Dividends
Helius Medical Technologies Inc is due to release its next quarterly earnings on 2025-May-01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Helius Medical Technologies Inc insiders own 17.70% of total outstanding shares while institutional holders control 6.31%, with the float percentage being 7.67%.
